FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2534448206> ?p ?o ?g. }

• W2534448206 abstract "Abstract Abstract 1216 Poster Board I-238 Background: PD-1 (Program Death-1), an immune inhibitory receptor and its ligands PD-L1 and PD-L2, participate in peripheral tolerance and play a key role in immune suppression and evasion mechanisms in cancer and chronic infectious diseases. PD-1 inhibits activation signals and functions as a pro-apoptotic receptor in effector lymphocytes, and consequently regulates the extent and duration of specific adaptive and innate immune responses. CT-011, a humanized antibody, blocks the function of PD-1, resulting in increased activities of T and NK cells in vitro and in enhanced tumor immunity in experimental tumor models. At the molecular level, the antibody enhances PI3K-mediated survival and trafficking signals, attenuates cell death in effector/memory (CD4+CD45RO+) cells, and enhances trafficking in response to Stromal Cell-derived Factor-1 (SDF-1). We hypothesized that CT-011 would enhance effector/memory cells in patients with DLBCL after AuSCT and delay recurrence. Methods: We treated 41 patients (pts) with DLBCL from 30-90 days after AuSCT with CT-011 and now report data on effector/memory and memory lymphocytes in the first 30 pts. CT-011 was given at a dose of 1.5mg/kg for 3 doses, 6 weeks apart. The primary endpoint was to determine the proportion of patients who have not relapsed or died within 18 months following autologous PBSCT, and it is too early for that analysis. Our secondary endpoint was to measure the number of effector /memory and memory lymphocytes before and after treatment, and those data are the subject of this report. Results: Flow cytometry analyses (Table) on pre (baseline: BL) and post-treatment blood samples from the first 30 pts enrolled show elevated levels of specific effector/memory and memory CD4+ T lymphocytes following treatment with CT-011; the median absolute number (ABS) of effector/memory CD4+CD45RO+CD62L-CCR7- cells was increased by +49% from BL (p<0.05) 6 weeks following the first treatment with CT-011, reaching a 2 fold increase in the ABS levels from BL and a 45% increase in the median percentage of the total lymphocyte population (p<0.05) 4 weeks after the third antibody treatment (week 16). The percentage of peripheral memory CD4+ CD62L-CD127+ cells was also increased by 61% from BL (median, p<0.05) on week 16. The observed increase, particularly of the effector/memory CD4+CD45RO+CD62L-CCR7- lymphocytes, a subset directly linked to PD-1 activity and to tumor immune surveillance, likely indicates a specific cellular response to CT-011, since no significant changes were observed for other memory cell subsets including CD4+CD45RO+CD62L+CCR7+cells, CD4+ CD62L+CD127+ cells, CD8+ CD62L-CD127+, CD8+CD62L+CD127+ cells or CD4+CD25+ FOXP3+ suppressor T cells. Overall no changes were observed in the level of total lymphocytes or T cells throughout 16 weeks of follow up from the 1st antibody treatment. Transient reduction of 32% (median, p<0.05) and 25% (median, p<0.05) in the ABS levels of CD3+CD8+ and CD3+CD45RO+, respectively, was observed at week 12, which recovered to baseline or higher levels on week 16. These changes may be explained by trafficking or recycling of CD8+ effector/memory cells from the periphery to target organs. Conclusions: Consistent with its mechanism of action, CT-011 increases the levels of specific CD4+ effector/memory and memory T lymphocytes. This is the first demonstration of safe induction of effector memory and memory lymphocytes, essential components of tumor- immune control, in lymphoma patients following AuSCT. This antibody may have promise for the treatment of lymphoma. Disclosures: Rotem-Yehudar: Cure Tech: Employment. Gordon:Cure Tech: Membership on an entity's Board of Directors or advisory committees." @default.
• W2534448206 created "2016-10-28" @default.
• W2534448206 creator A5002240997 @default.
• W2534448206 creator A5003670546 @default.
• W2534448206 creator A5010130956 @default.
• W2534448206 creator A5016956641 @default.
• W2534448206 creator A5042677328 @default.
• W2534448206 creator A5045583767 @default.
• W2534448206 creator A5045699031 @default.
• W2534448206 creator A5045723194 @default.
• W2534448206 creator A5049554397 @default.
• W2534448206 creator A5050962913 @default.
• W2534448206 creator A5052641327 @default.
• W2534448206 creator A5053410437 @default.
• W2534448206 creator A5058925624 @default.
• W2534448206 date "2009-11-20" @default.
• W2534448206 modified "2023-10-02" @default.
• W2534448206 title "The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+ Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT)." @default.
• W2534448206 doi "https://doi.org/10.1182/blood.v114.22.1216.1216" @default.
• W2534448206 hasPublicationYear "2009" @default.
• W2534448206 type Work @default.
• W2534448206 sameAs 2534448206 @default.
• W2534448206 citedByCount "0" @default.
• W2534448206 crossrefType "journal-article" @default.
• W2534448206 hasAuthorship W2534448206A5002240997 @default.
• W2534448206 hasAuthorship W2534448206A5003670546 @default.
• W2534448206 hasAuthorship W2534448206A5010130956 @default.
• W2534448206 hasAuthorship W2534448206A5016956641 @default.
• W2534448206 hasAuthorship W2534448206A5042677328 @default.
• W2534448206 hasAuthorship W2534448206A5045583767 @default.
• W2534448206 hasAuthorship W2534448206A5045699031 @default.
• W2534448206 hasAuthorship W2534448206A5045723194 @default.
• W2534448206 hasAuthorship W2534448206A5049554397 @default.
• W2534448206 hasAuthorship W2534448206A5050962913 @default.
• W2534448206 hasAuthorship W2534448206A5052641327 @default.
• W2534448206 hasAuthorship W2534448206A5053410437 @default.
• W2534448206 hasAuthorship W2534448206A5058925624 @default.
• W2534448206 hasConcept C126322002 @default.
• W2534448206 hasConcept C159654299 @default.
• W2534448206 hasConcept C193419808 @default.
• W2534448206 hasConcept C203014093 @default.
• W2534448206 hasConcept C2776090121 @default.
• W2534448206 hasConcept C2777367678 @default.
• W2534448206 hasConcept C2911091166 @default.
• W2534448206 hasConcept C502942594 @default.
• W2534448206 hasConcept C51785407 @default.
• W2534448206 hasConcept C71924100 @default.
• W2534448206 hasConcept C86803240 @default.
• W2534448206 hasConcept C8891405 @default.
• W2534448206 hasConceptScore W2534448206C126322002 @default.
• W2534448206 hasConceptScore W2534448206C159654299 @default.
• W2534448206 hasConceptScore W2534448206C193419808 @default.
• W2534448206 hasConceptScore W2534448206C203014093 @default.
• W2534448206 hasConceptScore W2534448206C2776090121 @default.
• W2534448206 hasConceptScore W2534448206C2777367678 @default.
• W2534448206 hasConceptScore W2534448206C2911091166 @default.
• W2534448206 hasConceptScore W2534448206C502942594 @default.
• W2534448206 hasConceptScore W2534448206C51785407 @default.
• W2534448206 hasConceptScore W2534448206C71924100 @default.
• W2534448206 hasConceptScore W2534448206C86803240 @default.
• W2534448206 hasConceptScore W2534448206C8891405 @default.
• W2534448206 hasLocation W25344482061 @default.
• W2534448206 hasOpenAccess W2534448206 @default.
• W2534448206 hasPrimaryLocation W25344482061 @default.
• W2534448206 hasRelatedWork W1972315079 @default.
• W2534448206 hasRelatedWork W1983476016 @default.
• W2534448206 hasRelatedWork W2032179749 @default.
• W2534448206 hasRelatedWork W2048785593 @default.
• W2534448206 hasRelatedWork W2163718404 @default.
• W2534448206 hasRelatedWork W2548997931 @default.
• W2534448206 hasRelatedWork W2551952866 @default.
• W2534448206 hasRelatedWork W2566770879 @default.
• W2534448206 hasRelatedWork W2604933953 @default.
• W2534448206 hasRelatedWork W2755232834 @default.
• W2534448206 hasRelatedWork W2885678300 @default.
• W2534448206 hasRelatedWork W2905769969 @default.
• W2534448206 hasRelatedWork W2927171417 @default.
• W2534448206 hasRelatedWork W2967949879 @default.
• W2534448206 hasRelatedWork W2977962525 @default.
• W2534448206 hasRelatedWork W2979612756 @default.
• W2534448206 hasRelatedWork W2982842897 @default.
• W2534448206 hasRelatedWork W3094376062 @default.
• W2534448206 hasRelatedWork W3146293900 @default.
• W2534448206 hasRelatedWork W2141595302 @default.
• W2534448206 isParatext "false" @default.
• W2534448206 isRetracted "false" @default.
• W2534448206 magId "2534448206" @default.
• W2534448206 workType "article" @default.